XFOR 8-K 2026-10-08

X4 Pharmaceuticals, Inc (XFOR) 8-K dated 2026-10-08 — accession 0001501697-26-000081. This URL is the filing, not the XFOR hub.

X4 Pharmaceuticals, Inc (XFOR) is a biotechnology company listed on NASDAQ.

X4 Pharmaceuticals, Inc filed a 8-K on 2026-10-08. Accession 0001501697-26-000081.

Cached items: 1.01, 1.02, 2.03, 3.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported XFOR revenue for 2025-12-31 was $6.5M. Net income was -$79.2M. Revenue was up 150.0% from 2024-12-31 to 2025-12-31. XFOR currently screens at market cap $382.0M.

Not investment advice. The XFOR SEC hub lists recent forms. The stock page is the research view.